↓ Skip to main content

A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

Overview of attention for article published in Journal of Translational Medicine, June 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter
1 tweeter
patent
2 patents
facebook
1 Facebook page

Citations

dimensions_citation
153 Dimensions

Readers on

mendeley
171 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia
Published in
Journal of Translational Medicine, June 2013
DOI 10.1186/1479-5876-11-143
Pubmed ID
Authors

Pawan K Gupta, Anoop Chullikana, Rajiv Parakh, Sanjay Desai, Anjan Das, Sanjay Gottipamula, Sagar Krishnamurthy, Naveen Anthony, Arun Pherwani, Anish S Majumdar

Abstract

Peripheral vascular disease of the lower extremities comprises a clinical spectrum that extends from no symptoms to presentation with critical limb ischemia (CLI). Bone marrow derived Mesenchymal Stem Cells (BM- MSCs) may ameliorate the consequences of CLI due to their combinatorial potential for inducing angiogenesis and immunomodulatory environment in situ. The primary objective was to determine the safety of BM- MSCs in patients with CLI.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
United Kingdom 2 1%
Ukraine 1 <1%
Italy 1 <1%
Sri Lanka 1 <1%
Japan 1 <1%
France 1 <1%
Unknown 161 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 32 19%
Student > Master 24 14%
Student > Ph. D. Student 22 13%
Other 21 12%
Student > Bachelor 14 8%
Other 35 20%
Unknown 23 13%
Readers by discipline Count As %
Medicine and Dentistry 57 33%
Agricultural and Biological Sciences 27 16%
Biochemistry, Genetics and Molecular Biology 19 11%
Nursing and Health Professions 9 5%
Engineering 9 5%
Other 18 11%
Unknown 32 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2018.
All research outputs
#5,105,623
of 17,351,915 outputs
Outputs from Journal of Translational Medicine
#774
of 3,202 outputs
Outputs of similar age
#46,265
of 163,765 outputs
Outputs of similar age from Journal of Translational Medicine
#1
of 1 outputs
Altmetric has tracked 17,351,915 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 3,202 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,765 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them